Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: JAK inhibitor

JAK inhibitors for AD in the real world

Presented By
Dr Yik Weng, National Skin Centre, Singapore
Conference
WCD 2023

31 August, 2023 18:02

Novel JAK1 inhibitor for patients with atopic dermatitis

Presented By
Jianzhong Zhang, Peking University People’s Hospital, China
Trial
Phase 3, QUARTZ3
Conference
WCD 2023

31 August, 2023 18:00

Patients with AA report high long-term regrowth rates with baricitinib

Presented By
Dr Maryanne Senna, Harvard Medical School, MA, USA
Trial
BRAVE-AA1 and BRAVE-AA2
Conference
WCD 2023

31 August, 2023 15:22

Can ritlecitinib deliver long-term efficacy in alopecia areata?

Presented By
Prof. Melissa Piliang, Cleveland Clinic, OH, USA
Trial
Phase 3, ALLEGRO
Conference
WCD 2023

31 August, 2023 15:18

Crohn’s disease: Upadacitinib improves endoscopic outcomes in participants with or without previous biologic failure

Presented By
Dr Brian Feagan, Western University, Canada
Trial
Phase 3, U-EXCEL, U-EXCEED, U-ENDURE
Conference
DDW 2023

13 June, 2023 13:50

Delgocitinib shows promise as topical therapy for chronic hand eczema

Presented By
Dr Robert Bissonnette, Innovaderm Research, Canada
Trial
Phase 3, DELTA 1
Conference
AAD 2023

15 May, 2023 10:58

Lichen planus: a future indication for baricitinib?

Presented By
Ms Angelina Hwang , Mayo Clinic College of Medicine, AZ, USA
Trial
Phase 2
Conference
AAD

15 May, 2023 09:58

Solid results for long-term therapy of UC with filgotinib

Presented By
Dr Brian Feagan, University of Western Ontario, Canada
Trial
Phase 3, SELECTION
Conference
ECCO 2023

4 May, 2023 15:01

Ruxolitinib mediates clonal evolution of RAS pathway mutations in MPN

Presented By
Dr Nabih Maslah, Université Paris Cité, France
Conference
ASH 2022

20 February, 2023 12:43

New analysis assesses the safety of tofacitinib regarding extended MACE

Presented By
Prof. Maya Buch, University of Manchester, United Kingdom
Trial
ORAL Surveillance
Conference
ACR 2022

1 December, 2022 14:18

Long-term improvement in alopecia areata with ritlecitinib therapy

Presented By
Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany
Trial
Phase 3, ALLEGRO-LT
Conference
EADV 2022

5 November, 2022 09:30

Deuruxolitinib achieves hair regrowth, even in patients with severe alopecia areata

Presented By
Prof. Brett King, Yale University School of Medicine, CT, USA
Trial
Phase 3, THRIVE-AA1
Conference
EADV 2022

5 November, 2022 09:18

Baricitinib possible therapeutic option for children with AD

Presented By
Dr Antonio Torrelo Fernández, Hospital Infantil Universitario Niño Jesús, Spain
Trial
Phase 3, BREEZE-AD-PEDS
Conference
EADV 2022

5 November, 2022 09:15

No adverse pregnancy outcomes in patients exposed to baricitinib

Conference
SPIN 2022

26 August, 2022 10:47

Alopecia areata: light at the end of the tunnel

Presented By
Prof. Maryanne Senna , Harvard Medical School, MA, USA
Trial
Phase 3, BRAVE-AA1, BRAVE-AA2
Conference
SPIN 2022

26 August, 2022 10:01

Baseline cardiovascular risk linked to higher rates of MACE in PsA and PsO patients receiving tofacitinib

Presented By
Prof. Lars Erik Kristensen , Copenhagen University Hospital, Denmark
Conference
EULAR 2022

21 July, 2022 17:30

A novel oral treatment possibility for non-radiographic axSpA on the horizon

Presented By
Prof. Filip van den Bosch , Ghent University, Belgium
Trial
Phase 3, SELECT-AXIS 2
Conference
EULAR 2022

21 July, 2022 17:17

IL-17 inhibition showing efficacy in GCA in phase 2 trials

Presented By
Prof. Jens Thiel, Medical University Graz, Austria
Trial
Phase 2, TitAIN
Conference
ACR 2021

14 January, 2022 11:05

Cycling JAK inhibitors shows similar effectiveness to switching to a bDMARD in difficult-to-treat RA

Presented By
Dr Manuel Pombo-Suarez, Hospital Clinico Universitario de Santiago De Compostela, Spain
Trial
JAK-pot
Conference
ACR 2021

14 January, 2022 11:03
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy